I have already posted that I saw this on TV, and looked it up online and could not find any links to the study. I hope they do put the results online at some point.
Here is what the "AI overview" said just now:
"Exercise & Sports Science Australia (ESSA) has warned that rapid weight loss from GLP-1 drugs (such as Ozempic) can lead to the equivalent of 20 years of age-related muscle decline in just one year if not managed properly. 1, 2]
Key Findings from the ESSA Warning (May 2026):
Muscle Loss Rate: Up to 40% of the weight lost using GLP-1 drugs can be lean body mass, including muscle.
Premature Frailty: This rapid loss of muscle (sarcopenia) creates a high risk of frailty, falls, and balance issues, essentially accelerating the body’s age-related muscle decline.
"Ozempic Face/Butt": The loss of fat and muscle, combined with reduced skin elasticity, can cause saggy "Ozempic face" and "Ozempic butt," making users look older.
Recommendation: ESSA is calling for mandated referrals to Accredited Exercise Physiologists (AEPs) at the point of prescribing these medications to protect muscle health. 1, 2, 3]"
From the Facebook link:
"ESSA CEO and Accredited Exercise Physiologist Katie Lyndon has been featured on page 3 of The Adelaide Advertiser, highlighting concerns that the rapid rise in GLP-1 weight loss medications is leaving some patients muscle-depleted and at risk of premature frailty.
ESSA is calling on governments to mandate referrals to Accredited Exercise Physiologists (AEPs) at the point of prescription, ensuring patients receive appropriate support to protect muscle health.
Today at the Activate Conference in Adelaide, ESSA is hosting a session: Exercise and weight loss in a world of lifestyle, stigma and pharmacology.
Presented by Dr Fiona Willer, AdvAPD, PhD, Dr Adelaide Boylan, Winthrop Professor Daniel Green and AEP Sara Slayman. Attendees will hear how, without appropriate intervention, these medications can accelerate muscle loss equivalent to up to 20 years of age-related decline in just 12 months."